Feasibility of Suprapubic Transvesical Endoscopic Prostatectomy

Beni-Suef University

Status: Active, not recruiting

Conditions: Prostate

Treatments: Other: Suprapubic transvesical endoscopic prostatectomy

Study type: Interventional

Funder types: Other

Identifiers

NCT07327424

FMBSUREC/01072025/Mohamed

Details and patient eligibility

About

In patients with penile prosthesis, any transurethral procedure could place the implant at risk. The use of long or extra-long resectoscope can be of some assistance; however, these are not available in many institutions. So suprapubic transvesical endoscopic prostatectomy is newly developed to bypass the anterior urethra. Thus, the aim of this study is to determine safety and efficacy of Suprapubic Transvesical endoscopic prostatectomy.

Enrollment: 80 estimated patients

Sex: Male

Ages: 55+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male patients with moderate to severe lower urinary tract symptoms ( IPSS score ≥ 8 ) indicated for surgical intervention with prostate size less than 120 cc.

Exclusion criteria

• History of previous pelvic surgery, urothelial cancer, kidney transplantation, uncontrolled coagulopathy, and significant central fat accumulation that could potentially increase the risk during transvesical access(body mass index not exceeding 27 kg/m2)

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

80 participants in 1 patient group

Suprapubic Transvesical endoscopic prostatectomy

Experimental group

Treatment:

Other: Suprapubic transvesical endoscopic prostatectomy